[
    [
        {
            "time": "2018-03-20",
            "original_text": "欢迎BAT回归A股，但我不會买它们的股票",
            "features": {
                "keywords": [
                    "BAT",
                    "回归",
                    "A股"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "欢迎BAT回归A股，但我不會买它们的股票",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "这个板块本轮反弹堪比“独角兽”！价投大旗能否由它扛起？（附股）",
            "features": {
                "keywords": [
                    "板块",
                    "反弹",
                    "独角兽",
                    "价值投资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新兴行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "这个板块本轮反弹堪比“独角兽”！价投大旗能否由它扛起？（附股）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "现在市场上有哪些P2P平台比较安全？",
            "features": {
                "keywords": [
                    "P2P",
                    "安全"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "现在市场上有哪些P2P平台比较安全？",
                "Correlation": 2,
                "Sentiment": 4,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "郑眼看盘：多空均衡 横向震荡为主",
            "features": {
                "keywords": [
                    "多空",
                    "均衡",
                    "横向震荡"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "郑眼看盘：多空均衡 横向震荡为主",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "沪指收复年线关口 多头是时候亮剑了？——道达投资手记",
            "features": {
                "keywords": [
                    "沪指",
                    "年线",
                    "多头"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "指数"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沪指收复年线关口 多头是时候亮剑了？——道达投资手记",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "最高62.54%！一季度恒瑞、科伦、中国生物制药等医药股疯涨！背后逻辑是什么？",
            "features": {
                "keywords": [
                    "医药股",
                    "恒瑞",
                    "科伦",
                    "中国生物制药",
                    "涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最高62.54%！一季度恒瑞、科伦、中国生物制药等医药股疯涨！背后逻辑是什么？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "中富金石：两市低开高走双双收涨 医药股全线爆发",
            "features": {
                "keywords": [
                    "两市",
                    "低开高走",
                    "医药股",
                    "爆发"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中富金石：两市低开高走双双收涨 医药股全线爆发",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "[优异评级]医药生物行业研究简报：国务院机构改革方案亮相 注射剂研发技术指导意见发布",
            "features": {
                "keywords": [
                    "医药生物",
                    "国务院",
                    "机构改革",
                    "注射剂",
                    "研发"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[优异评级]医药生物行业研究简报：国务院机构改革方案亮相 注射剂研发技术指导意见发布",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "[买入评级]复星医药(600196)点评：引进美国即将上市的创新药 产品线梯队进一步丰富",
            "features": {
                "keywords": [
                    "复星医药",
                    "创新药",
                    "产品线",
                    "梯队"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]复星医药(600196)点评：引进美国即将上市的创新药 产品线梯队进一步丰富",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]